Medical News

Stress Hyperglycemia is Predictive of Clinical Outcomes in P...
BMC Neurol.
Stress hyperglycemia, calculated by glucose-to-HbA1c ratio, was independently correlated with worse functional...
28 Jun 2022

Multidrug-Resistant Acinetobacter baumannii May Cause Patien...
Can J Infect Dis Med Microbiol.
Polymicrobial AB-BSI accounted for a significant proportion among all AB-BSI, and it did not influence mortality...
28 Jun 2022

Temporal Trends in Antimicrobial Prescribing During Hospital...
JAMA Intern Med.
In this multihospital cohort study, the time to first antimicrobial for sepsis decreased over time, but this trend...
28 Jun 2022

Usefulness of Fibrosis-4 (FIB-4) Score and Metabolic Alterat...
Int Emerg Med.
Hepatic steatosis had no impact on disease course. The presence of metabolic alterations is associated with severe...
27 Jun 2022
eCMEs
Key Trials
Treatment with Casirivimab and Imdevimab Lowers Hospitalization Rates in High Risk Patients with Mild-to-Moderate COVID-19
The results of this real-world study demonstrated that treatment with casirivimab-imdevimab significantly lowered the rate of hospitalization among...
Casirivimab and Imdevimab Antibody Cocktail Clinically Beneficial in High Risk COVID-19 Patients
Casirivimab and Imdevimab antibody cocktail resulted in lesser requirement of mechanical ventilation and high-flow oxygen with no deaths as compared...
RECOVERY Trial: Efficacy and Safety of Casirivimab and Imdevimab Combination in Hospitalized COVID-19 Patients
RECOVERY Trial evaluated efficacy and safety of casirivimab and imdevimab combination in hospitalized COVID-19 patients. The study showed that in...
REGEN-COV Reduces Risk of Hospitalization and Shortens Time to Resolution of Symptoms in Symptomatic COVID-19 Patients
As per the results of this phase 3, administration of REGEN-COV decreased the risk of Covid-19–related hospitalization or death from any cause....
Our Publications
Barijak (Barictinib) Monograph
Barictinib can be useful addition for treatment of Moderate to Severe Covid 19 patients in combination with Remdesivir. Barcitinib inhibits the...
Cipmolnu (Molnupiravir) Monograph
This monograph overviews in-vitro/clinical evidence for Molnupiravir efficacy, safety and positioning.
Molnupiravir: Fact Sheet for Healthcare Givers and Recipients
This fact sheet contains the factual details about the drug molnupiravir, its restricted use under emergency situation, dosage, side effects etc....
Molnupiravir - FAQ Booklet
This document addresses frequently asked questions related to oral antiviral drug Molnupiravir in the treatment of Covid-19.